zł337.20
0.36%
Warsaw, Oct 23, 04:46 pm CEST. Closed.
ISIN
PLSNKTK00019
Symbol
SNT

Synektik Stock price

zł334.20
-15.80 4.51% 1M
+46.00 15.96% 6M
+51.60 18.26% YTD
+76.20 29.53% 1Y
+275.60 470.31% 3Y
+306.40 1,102.16% 5Y
+317.00 1,843.02% 10Y
+324.60 3,381.25% 20Y
Warsaw, Closing price Fri, Oct 23 2026
-1.80 0.54%
ISIN
PLSNKTK00019
Symbol
SNT

AI Insights on Synektik Insights AI Insights on Synektik

How does the company make money?
Who are the company’s main competitors?

Is Synektik a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,102 stocks worldwide.

Key metrics

Basic
Market capitalization
zł2.9b
Enterprise Value
zł2.9b
Net debt
zł20.9m
Cash
zł36.1m
Shares outstanding
8.5m
Valuation
P/E
5.8
P/S | estimate
1.9 | 3.0
EV/Sales | estimate
1.9 | 3.0
EV/FCF | ex SBC
33.3 | -
P/B
18.1
Dividends
DPS
zł10.75
Yield 1Y | 5Y
3.2% | 3.3%
Growth 1Y | 5Y
30.3% | 88.6%
Payout 1Y | 3Y
68.9% | 42.7%
Increased
4 Years
Financials
Revenue | estimate
zł1.5b | zł970.7m
EBITDA
zł376.9m
EBIT
zł355.7m
Net Income
zł492.2m
Free Cash Flow | ex SBC
zł86.7m | -
Growth
Revenue | estimate
63.5% | 42.5%
EBITDA
90.3%
EBIT
98.4%
Net Income
269.8%
Free Cash Flow
105.8%
Margin
Gross
35.5%
EBITDA
25.1%
EBIT
23.6%
Net
32.7%
Free Cash Flow | ex SBC
5.8% | -
Financial Health
Equity Ratio
45.8%
Return on Equity
45.9%
ROCE
155.6%
ROIC
126.7%
Debt/Equity
0.4
More
EPS
zł57.7
FCF per Share
zł10.2
Short interest
-
Employees
231
Rev per Employee
zł3.0m

Synektik Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Synektik forecast:

7x Buy
78%
2x Hold
22%

Analyst Opinions

9 Analysts have issued a Synektik forecast:

Buy
78%
Hold
22%

Financial data from Synektik

Mar '26
+/-
%
1,505 1,505
64% 64%
100%
- Direct Costs 970 970
58% 58%
64%
534 534
75% 75%
36%
- Selling and Administrative Expenses 171 171
77% 77%
11%
- Research and Development Expense 6.68 6.68
77% 77%
0%
377 377
90% 90%
25%
- Depreciation and Amortization 21 21
13% 13%
1%
EBIT (Operating Income) EBIT 356 356
98% 98%
24%
Net Profit 492 492
270% 270%
33%

In millions PLN.

Don't miss a Thing! We will send you all news about Synektik directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Synektik SA provides medical and information technology solutions. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2011-08-09. The company produces PACS software which allows running a diagnostic imaging laboratory. The company runs a research laboratory which performs acceptance and specialist tests of X-ray equipment. The firm sells medical equipment and operates a services center for imaging equipment. Synektik SA is a partner of Siemens. On November 28, 2013, the Company raised its stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o to 100%.

Head office Poland
CEO Mr. Kozanecki
Employees 231
Website www.synektik.com.pl

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today